LENZ Therapeutics Partners Arrotex to Launch VIZZ in ANZ
SAN DIEGO & MELBOURNE, Australia, June 24, 2026 LENZ Therapeutics has significantly expanded the international commercialization strategy for its...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
SAN DIEGO & MELBOURNE, Australia, June 24, 2026 LENZ Therapeutics has significantly expanded the international commercialization strategy for its...
TAIPEI, Feb. 23, 2026 — Formosa Pharmaceuticals announced an exclusive licensing agreement with Arrotex Pharmaceuticals granting commercialization rights for...
